Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 18/6/2018
SIETES contiene 92381 citas

 1 a 20 de 55 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
2. Cita con resumen
Hirschler B. UK bans Sanofi epilepsy drug without pregnancy prevention plan. Reuters Health News 2018:24 de abril. [Ref.ID 102553]
3. Cita con resumen
Pennell PB. Antiepileptic drugs in pregnancy — Quick decisions with long-term consequences. JAMA Neurology 2018:1. [Ref.ID 102464]
4. Cita con resumen
Elkjær LS, Bech BH, Sun Y, Laursen TM, Christensen J. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children. JAMA Neurology 2018:1. [Ref.ID 102463]
5.Enlace a cita original Cita con resumen
Anónimo. Medicines related to valproate: risk of abnormal pregnancy outcomes. Drug Safety Update 2015;8:1. [Ref.ID 98832]
6.Enlace a cita original
Doan T, Ware R, McPherson L, van Dooren K, Bain C, Carrington S, Einfeld S, Tonge B, Lennox N. Psychotropic medication use in adolescents with intellectual disability living in the community. Pharmacoepidemiol Drug Saf 2014;23:69-76. [Ref.ID 97001]
7. Cita con resumen
Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262-73. [Ref.ID 83539]
8.Tiene citas relacionadas
Tyrer P, Oliver-Africano P, Murphy D, Crawford M, Harley D. Antipsychotics in individuals with intellectual disability. Lancet 2008;371:1502. [Ref.ID 82799]
9.Tiene citas relacionadas
Gainotti S, Galeotti F, Izzicupo F, Petrini C, Raschetti R. Antipsychotics in individuals with intellectual disability. Lancet 2008;371:1501-2. [Ref.ID 82798]
10.Tiene citas relacionadas
Turk J, Bramble D, Levitas A. Antipsychotics in individuals with intellectual disability. Lancet 2008;371:1501. [Ref.ID 82797]
11.Tiene citas relacionadas
Trollor JN, Somerville ER, Somerville HM. Antipsychotics in individuals with intellectual disability. Lancet 2008;371:1501. [Ref.ID 82796]
12.Tiene citas relacionadas Cita con resumen
Tyrer P, Oliver-Africano P, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M. Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial. Lancet 2008;371:57-63. [Ref.ID 81861]
13.Tiene citas relacionadas Cita con resumen
Matson JL, Wilkins J. Antipsychotic drugs for aggression in intellectual disability. Lancet 2008;371:9-10. [Ref.ID 81854]
14.Tiene citas relacionadas
Levy HL, Milanowski A, Chakrapani A, Cleary M, Lee P, Trefz FK, Whitley CB, Feillet F, Feigenbaum AS, Bebchuk JD, Christ-Schmidt H, Dorenbaum A, for the Sapropterin Research Group. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenulketonuria: a phase III randomised placebo-controlled study. Lancet 2007;370:504-10. [Ref.ID 80886]
15.Tiene citas relacionadas Cita con resumen
Pey AL, Martinez A. Tetrahydrobiopterin for patients with phenylketonuria. Lancet 2007;370:462-3. [Ref.ID 80880]
16. Cita con resumen
Grandjean P, Landrigan PJ. Developmental neurotoxicity of industrial chemicals. Lancet 2006;368:2167-78. [Ref.ID 78680]
18.Tiene citas relacionadas Cita con resumen
de Koning TJ, Klomp LWJ, van Oppen ACC, Beemer FA, Dorland L, van den Berg IET, Berger R. Prenatal and early postnatal treatment in 3-phosphoglycerate-dehydrogenase deficiency. Lancet 2004;364:2221-2. [Ref.ID 72194]
19.Tiene citas relacionadas Cita con resumen
Pollitt R J, Sharrard MJ. Treating rare inborn errors of metabolism. Lancet 2004;364:2158-60. [Ref.ID 72183]
20.Tiene citas relacionadas Cita con resumen
Valent F, Little D'A, Bertollini R, Nemer L E, Barbone F, Tamburlini G. Burden of disease attributable to selected environmental factors and injury among children and adolescents in Europe. Lancet 2004;363:2032-9. [Ref.ID 70482]
Seleccionar todas
 1 a 20 de 55 siguiente >>